BMS Mead Johnson Impending Changes Continue Reorganization Efforts
This article was originally published in The Tan Sheet
An organizational shakeup at Mead Johnson is being executed by parent Bristol-Myers Squibb to help reverse disappointing results in recent quarters at the nutritionals division.
You may also be interested in...
Bristol-Myers Squibb's decision to divest its Clairol cosmetics and Zimmer orthopedic implants businesses in the next 6 to 12 months is part of the company's strategy to focus its resources on its core medicines segments.
The October launch of Children's Motrin Cold liquid will be supported with an $8 mil. TV and print ad campaign, McNeil Consumer Healthcare announced Aug. 14.
Ongoing studies of Bristol-Myers Squibb's newly approved Vaniqa prescription hair removal drug could broaden the topical cream's target population to include men. FDA approved the product for removal of women's facial hair July 27.